Full Text
PMS18 ESTIMATION OF COSTS RELATED TO ADVERSE EVENTS IN NSAID TREATMENT OF OSTEOARTHRITIS - A COMPARISON BETWEEN CELECOXIB AND IBUPROFEN USING A VALIDATED MODEL

Abstract

Authors

A Svedbom F Borgstrom S Holmstrom C Miltenburger

Back to Volume 12, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×